Ferritin Quantitative Test

SARS-CoV-2 Antigen Rapid Qualitative Test

The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.
Product Detail

Product Features

High sensitivity and specificity

Test results conveniently available in 20-30 minutes

Long shelf life of 24 months with room temperature storage

QR-code based patient tracking


Clinical Performance

Relative Sensitivity: 96.00% (88.75% - 99.17%)

Relative Specificity: 100.00% (98.34% - 100.00%)

Accuracy: 98.98% (97.06 – 99.79%)



Testing process for the SARS-CoV-2 Rapid Antigen Test

 

① Transfer 6 drops of extraction buffer to a tube.

② Insert the swab into an extraction buffer tube. While squeezing the buffer tube, stir the swab more than 10 seconds.

③ Remove the swab while squeezing the sides of the tube to extract the liquid from the swab.

④ Press the nozzle cap tightly onto the tube. Continue with 3a. Performing a test.

⑤ Place the test device on a flat surface and apply 2 drops of extracted sample in a 90° angle to the specimen well of the cassette

⑥ Read the test result at 20 to 30 mins.



Interpreting Test Results




Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
SARS-CoV-2 IgG/IgM Rapid Test
SARS-CoV-2 IgG/IgM Rapid Qualitative Test
The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.
Neutralizing Antibody Rapid Test
SARS-CoV-2 Neutralizing Antibody Rapid Test
Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
IL-6 Rapid Quantitative Test
IL-6 Rapid Quantitative Test
IL-6 is a valuable biomarker for early detection and monitoring of inflammatory conditions, particularly in the context of bacterial infections and sepsis.
Biotime Myo Rapid Quantitative Test
Myo Rapid Quantitative Test
Myo is the earliest marker after AMI, and it is a sensitive and accurate indicator to judge whether there is reperfusion in thrombolytic therapy. Biotime Myo test kit is mainly used to detect Myo quantity in human serum and plasma samples.
PRL Rapid Quantitative Test (Chemiluminescence Immunoassay)
PRL Rapid Quantitative Test (Chemiluminescence Immunoassay)
PRL Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Prolactin (PRL) concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases. 
BNP Rapid Quantitative Test (Chemiluminescence Immunoassay)
BNP Rapid Quantitative Test (Chemiluminescence Immunoassay)
BNP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Brain natriuretic peptide (BNP) concentration in human plasma that contains EDTA anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.
hs-cTnI Rapid Quantitative Test (Chemiluminescence Immunoassay)
hs-cTnI Rapid Quantitative Test (Chemiluminescence Immunoassay)
hs-cTnI Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the high sensitivity cardiac troponin I (hs-cTnI) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.
HBP Rapid Quantitative Test (Chemiluminescence Immunoassay)
HBP Rapid Quantitative Test (Chemiluminescence Immunoassay)
HBP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Heparin binding protein (HBP) concentration in human plasma that contains Sodium Citrate samples, mainly used for auxiliary diagnosis of inflammation diseases.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact